ISSN: 1697-090X


Indice del volumen
Volume index

Comité Editorial
Editorial Board

Comité Científico
Scientific Committee

Normas para los autores
Instruction to Authors

Derechos de autor Copyright


    Rev Electron Biomed / Electron J Biomed 2019;1:2-6.



    Carlos G. Musso, MD. PhD.

    Nephrology Division - Ageing Biology Unit
    Hospital Italiano de Buenos Aires,

    carlos.musso @

    Version en español

      The estimated incidence rate of acute kidney injury (AKI) in hospitalized patients is 2-5%, and rises up to 67% on intensive care unit (ICU) patients1. In addition, when AKI is not solved, it turns into another serious condition as is chronic kidney disease2.

      For this reason, achieving an early diagnose of AKI would be a significant accomplishment since it will allow physicians to perform a prompt management of this condition, and consequently to optimize its evolution and prognosis. However, it is currently very difficult to obtain an early diagnosis of AKI due to the following reasons:

      First, current AKI diagnosis is based on KDIGO criteria which consists of a significantly acute elevation of serum creatinine (sCr) levels (sCr increase >0.3 mg/dl or 1.5 - 1.9 times baseline value), or a significant and prolonged reduction in urinary rate (urinary output <0.5 ml/kg/hour throughout 6 hours)3. These criteria make it difficult to achieve an early AKI diagnosis since: on one hand, a mild serum creatinine elevation does not imply a mild glomerular filtration rate reduction but a significantly big one. On the other hand, a precise urinary volume collection is not easy to achieve in all patients, except in those admitted in ICU.

      Second, novel biomarkers (subclinical) have recently been proposed for achieving an early AKI diagnosis4. However, the problem is that these novel biomarkers are expensive and not universally available in all medical centers. Moreover, they do not guarantee an early AKI detection since their request depends on the physician´s clinical suspicion, which is based on the above mentioned KDIGO criteria.

      From the above, it is clear that a more effective clinical strategy is needed to achieve an early diagnosis of AKI. In this sense, it could be proposed the following idea: since renal physiological changes generally precede kidney parenchymal damage, and that this phenomenon can be detected by changes in urine, it could be evaluated if daily urinary evaluation of simple and relatively inexpensive physiological urinary parameters (eg: urinary indices) are carried out, it would be possible to predict the early appearance of AKI through a significant change in its basal urinary values detected immediately before AKI clinical diagnosis5-6. This diagnostic strategy could be named renal urinary monitoring.

      In conclusion, it is proposed here that in order to make an early diagnosis of AKI feasible, its current diagnostic strategy should be changed, and that it should be evaluated whether the performance of renal urinary monitoring, carried out since the patient's admission, could be effective (efficient and feasible) to achieve this purpose.


        1.- Goldberg R, Dennen P. Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis. 2008;15(3):297-307.

        2.- Rennke H, Denker B. Renal Pathophysiology. Philadelphia. Lippincott Williams & Wilkins. 1994: 267-290.

        3.- KDIGO Clinical practice guidelline for acute kidney injury. Kidney int suppl. 2012; 2(1): 1-38.

        4.- Beker BM, Corleto MG, Fieiras C, Musso CG.Novel acute kidney injury biomarkers: their characteristics, utility and concerns. Int Urol Nephrol. 2018;50(4):705-713.

        5.- Benozzi P, Vallecillo B, Musso CG. Urinary Indices: Their Diagnostic Value in Current Nephrology. Front Med Health Re. 2017s; 1(1): 1-5.

        6.- Musso CG, Terrasa S, Ciocchini M, González-Torres H, Aroca-Martínez G. Looking for a better definition and diagnostic strategy for acute kidney injury: a new proposal.Arch Argent Pediatr. 2019;117(1):4-5.

    Carlos G. Musso, MD. PhD.
    Nephrology Division - Ageing Biology Unit
    Hospital Italiano de Buenos Aires,
    Buenos Aires. Argentina
    Email: carlos.musso @